Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells

Frontiers in Oncology

Volumn 3 APR, Issue , 2013, Pages

  Vélez, Juliana ^a   Hail, Numsen ^b   Konopleva, Marina ^b   Zeng, Zhihong ^b   Kojima, Kensuke ^b   Samudio, Ismael ^a   Andreeff, Michael ^b  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anaplerosis; Apoptosis; Cataplerosis; Electron transport; Krebs cycle; Microenvironment; Mitochondrial uncoupling; OXPHOS

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; DIHYDROOROTATE DEHYDROGENASE; FRUCTOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; OXALOACETIC ACID; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUCCINYL COENZYME A;

ALLOSTERISM; ANAPLEROSIS; APOPTOSIS; CATAPLEROSIS; CELL KINETICS; CELL METABOLISM; CELL SURVIVAL; CITRIC ACID CYCLE; ELECTRON TRANSPORT; FATTY ACID OXIDATION; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXIC CELL; LEUKEMIA CELL; MITOCHONDRIAL DYNAMICS; OXIDATIVE PHOSPHORYLATION; OXIDATIVE PHOSPHORYLATION UNCOUPLING; REGULATORY MECHANISM; REVIEW; TUMOR MICROENVIRONMENT;

EID: 84890701538     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00067     Document Type: Review

References (60)

1. Abu-Hamad, S., Zaid, H., Israelson, A., Nahon, E., and Shoshan-Barmatz, V. (2008). Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: Mapping the site of binding. J. Biol. Chem. 283, 13482-13490.
2. Amellem, O., Löffler, M., and Pettersen, E. O. (1994). Regulation of cell proliferation under extreme and moderate hypoxia: The role of pyrimidine (deoxy)nucleotides. Br. J. Cancer 70, 857-866.
3. Arany, I., Ember, I., and Rady, P. (1988). Subcellular distribution of hexokinase in leukemic and stimulated lymphoid cells of mice. Haematologia (Budap.) 21, 109-114.
4. Armstrong, J. S., Steinauer, K. K., French, J., Killoran, P. L., Walleczek, J., Kochanski, J., et al. (2001). Bcl-2 inhibits apoptosis induced by mitochondrial uncoupling but does not prevent mitochondrial transmembrane depolarization. Exp. Cell Res. 262, 170-179.
5. Benito, J., Shi, Y., Szymanska, B., Carol, H., Boehm, I., Lu, H., et al. (2011). Pronounced hypoxia in models of murine and human leukemia: High efficacy of hypoxia-activated prodrug PR-104. PLoS ONE 6:e23108. doi:10.1371/journal.pone.0023108
6. Berg, J. M., Stryer, L., and Tymoczko, J. L. (2002). Biochemistry. New York: W.H. Freeman.
7. Beuneu, C., Auger, R., Loffler, M., Guissani, A., Lemaire, G., and Lepoivre, M. (2000). Indirect inhibition of mitochondrial dihydroorotate dehydrogenase activity by nitric oxide. Free Radic. Biol. Med. 28, 1206-1213.
8. Bloch-Frankenthal, L., Langan, J., Morris, H. P., and Weinhouse, S. (1965). Fatty acid oxidation and ketogenesis in transplantable liver tumors. Cancer Res. 25, 732-736.
9. Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., et al. (2007). A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37-51.
10. Chen, Z., Zhang, H., Lu, W., and Huang, P. (2009). Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochim. Biophys. Acta 1787, 553-560.
11. Chiara, F., Castellaro, D., Marin, O., Petronilli, V., Brusilow, W. S., Juhaszova, M., et al. (2008). Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS ONE 3:e1852. doi:10.1371/journal.pone.0001852
12. de Pablo, M. A., Susin, S. A., Jacotot, E., Larochette, N., Costantini, P., Ravagnan, L., et al. (1999). Palmitate induces apoptosis via a direct effect on mitochondria. Apoptosis 4, 81-87.
13. DeBerardinis, R. J. (2011). Serine metabolism: Some tumors take the road less traveled. Cell Metab. 14, 285-286.
14. DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., et al. (2007). Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U.S.A. 104, 19345-19350.
15. Derdak, Z., Mark, N. M., Beldi, G., Robson, S. C., Wands, J. R., and Baffy, G. (2008). The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. Cancer Res. 68, 2813-2819.
16. Evans, D. R., and Guy, H. I. (2004). Mammalian pyrimidine biosynthesis: Fresh insights into an ancient pathway. J. Biol. Chem. 279, 33035-33038.
17. Fiegl, M., Samudio, I., Clise-Dwyer, K., Burks, J. K., Mnjoyan, Z., and Andreeff, M. (2009). CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood 113, 1504-1512.
18. Folmes, C. D., Dzeja, P. P., Nelson, T. J., and Terzic, A. (2012). Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell 11, 596-606.
19. Forman, J. H., and Kennedy, J. (1975). Superoxide production and electron transport in mitochondrial oxidation of dihydroorotic acid. J. Biol. Chem. 250, 4322-4326.
20. Gambert, S., and Ricquier, D. (2007). Mitochondrial thermogenesis and obesity. Curr. Opin. Clin. Nutr. Metab. Care 10, 664-670.
21. Goodwin, G. W., and Taegtmeyer, H. (2000). Improved energy homeostasis of the heart in the metabolic state of exercise. Am. J. Physiol. Heart Circ. Physiol. 279, H1490-1501.
22. Hail, N. Jr., Chen, P., Rower, J., and Bushman, L. R. (2010a). Teriflunomide encourages cytostatic and apoptotic effects in premalignant and malignant cutaneous keratinocytes. Apoptosis 15, 1234-1246.
23. Hail, N. Jr., Chen, P., and Wempe, M. F. (2010b). The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells. Free Radic. Biol. Med. 49, 2001-2009.
24. Hail, N. Jr., and Lotan, R. (2009). Cancer chemoprevention and mitochondria: Targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state. Mol. Nutr. Food Res. 53, 49-67.
25. Konopleva, M., Konoplev, S., Hu, W., Zaritskey, A. Y., Afanasiev, B. V., and Andreeff, M. (2002). Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 16, 1713-1724.
26. Krebs, H. A., and Johnson, W. A. (1937). Acetopyruvic acid (alphagamma-diketovaleric acid) as an intermediate metabolite in animal tissues. Biochem. J. 31, 772-779.
27. Krebs, H. A., Salvin, E., and Johnson, W. A. (1938). The formation of citric and alpha-ketoglutaric acids in the mammalian body. Biochem. J. 32, 113-117.
28. Kui, L., Weiwei, Z., Ling, L., Daikun, H., Guoming, Z., Linuo, Z., et al. (2009). Ghrelin inhibits apoptosis induced by high glucose and sodium palmitate in adult rat cardiomyocytes through the PI3K-Akt signaling pathway. Regul. Pept. 155, 62-69.
29. Lagadinou, E. D., Sach, A., Callahan, K., Rossi, R. M., Neering, S. J., Minhajuddin, M., et al. (2013). BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12, 329-341.
30. Lakaschus, G., Krüger, H., Heese, D., and Löffler, M. (1991). Evidence from in vitro studies that dihydroorotate dehydrogenase may be a source of toxic oxygen species. Adv. Exp. Med. Biol. 309A, 361-364.
31. Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., et al. (2012). Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15, 110-121.
32. Lenaz, G. (2001). The mitochondrial production of reactive oxygen species: Mechanisms and implications in human pathology. IUBMB Life 52, 159-164.
33. Löffler, M. (1989). The biosynthetic pathway of pyrimidine (deoxy)nucleotides: A sensor of oxygen tension necessary for maintaining cell proliferation? Exp. Cell Res. 182, 637-680.
34. Low, I. C., Chen, Z. X., and Pervaiz, S. (2010). Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid. Redox Signal. 13, 807-819.
35. Luby-Phelps, K. (2000). Cytoarchitecture and physical properties of cytoplasm: Volume, viscosity, diffusion, intracellular surface area. Int. Rev. Cytol. 192, 189-221.
36. Lynen, F. (1951). Die Rolle der Phosphorsaeure bei Dehydrierungsvorgaengen und ihre biologische Bedeutung. Naturwissenschaften 30, 398-406.
37. Majewski, N., Nogueira, V., Bhaskar, P., Coy, P. E., Skeen, J. E., Gottlob, K., et al. (2004a). Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell 16, 819-830.
38. Majewski, N., Nogueira, V., Robey, R. B., and Hay, N. (2004b). Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol. Cell. Biol. 24, 730-740.
39. Mathupala, S. P., Ko, Y. H., and Pedersen, P. L. (2010). The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim. Biophys. Acta 1797, 1225-1230.
40. Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., et al. (2012). Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380-384.
41. Ringshausen, I., Oelsner, M., Bogner, C., Peschel, C., and Decker, T. (2008). The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells. Leukemia 22, 635-638.
42. Ronzoni, E., and Ehrenfest, E. (1936). The effect of dinitrophenol on the metabolism of frog muscle. J. Biol. Chem. 15, 749.
43. Rückemann, K., Fairbanks, L. D., Carrey, E. A., Hawrylowicz, C. M., Richards, D. F., Kirschbaum, B., et al. (1998). Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J. Biol. Chem. 273, 21682-21691.
44. Samudio, I., Fiegl, M., and Andreeff, M. (2009). Mitochondrial uncoupling and the Warburg effect: Molecular basis for the reprogramming of cancer cell metabolism. Cancer Res. 69, 2163-2166.
45. Samudio, I., Fiegl, M., McQueen, T., Clise-Dwyer, K., and Andreeff, M. (2008). The Warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation. Cancer Res. 68, 5198-5205.
46. Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., et al. (2010). Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest. 120, 142-156.
47. Sawamukai, N., Saito, K., Yamaoka, K., Nakayamada, S., Ra, C., and Tanaka, Y. (2007). Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells. J. Immunol. 179, 6479-6484.
48. Scott, D. A., Richardson, A. D., Filipp, F. V., Knutzen, C. A., Chiang, G. G., Ronai, Z. A., et al. (2011). Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. J. Biol. Chem. 286, 42626-42634.
49. Shawver, L. K., Schwartz, D. P., Mann, E., Chen, H., Tsai, J., Chu, L., et al. (1997). Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Clin. Cancer Res. 3, 1167-1177.
50. Sheets, A. R., Fulop, P., Derdak, Z., Kassai, A., Sabo, E., Mark, N. M., et al. (2008). Uncoupling protein-2 modulates the lipid metabolic response to fasting in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G1017-G1024.
51. Shoshan-Barmatz, V., and Ben-Hail, D. (2012). VDAC, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion 12, 24-34.
52. Shoshan-Barmatz, V., De Pinto, V., Zweckstetter, M., Raviv, Z., Keinan, N., and Arbel, N. (2010). VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Aspects Med. 31, 227-285.
53. Smerc, A., Sodja, E., and Legisa, M. (2011). Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism. PLoS ONE 6:e19645. doi:10.1371/journal.pone.0019645
54. Traut, T. W. (1994). Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem. 140, 1-22.
55. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314.
56. Warburg, O., Posener, K., and Negelein, E. (1924). über den Stoffwechsel der Tumoren. Biochem. Z. 152, 319-344.
57. Weinhouse, S. (1972). Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture. Cancer Res. 32, 2007-2016.
58. Wilkins, H. M., Marquardt, K., Lash, L. H., and Linseman, D. A. (2012). Bcl-2 is a novel interacting partner for the 2-oxoglutarate carrier and a key regulator of mitochondrial glutathione. Free Radic. Biol. Med. 52, 410-419.
59. Wise, D. R., Ward, P. S., Shay, J. E., Cross, J. R., Gruber, J. J., Sachdeva, U. M., et al. (2011). Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad. Sci. U.S.A. 108, 19611-19616.
60. Xu, X., Williams, J. W., Gong, H., Finnegan, A., and Chong, A. S. (1996). Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation. Biochem. Pharmacol. 52, 527-534.